Cargando…
Modified Sijunzi decoction in the treatment of ulcerative colitis in the remission phase: study protocol for a series of N-of-1 double-blind, randomised controlled trials
BACKGROUND: Modified Sijunzi decoction (SJZD) has been used to treat ulcerative colitis (UC) in remission. However, more rigorous clinical trials are necessary to evaluate its effectiveness. Therefore, a series of single-case randomised controlled trials (N-of-1 trials) is proposed to compare the ef...
Autores principales: | Chen, Yi-ming, Deng, Jie-min, Wen, Yi, Chen, Bin, Hou, Jiang-tao, Peng, Bin, Zhang, Shi-jing, Mi, Hong, Jiang, Qi-long, Wu, Xia-lin, Liu, Feng-bin, Chen, Xin-lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218572/ https://www.ncbi.nlm.nih.gov/pubmed/32398112 http://dx.doi.org/10.1186/s13063-020-04315-0 |
Ejemplares similares
-
Clinical efficacy and safety of modified Sijunzi decoction for the treatment of ulcerative colitis: A protocol for a systematic review and meta-analysis
por: Tian, Shu Wei, et al.
Publicado: (2021) -
Assessment of the targeted effect of Sijunzi decoction on the colorectal cancer microenvironment via the ESTIMATE algorithm
por: Du, Jiaxin, et al.
Publicado: (2022) -
Sijunzi Decoction Targets IL1B and TNF to Reduce Neutrophil Extracellular Traps (NETs) in Ulcerative Colitis: Evidence from Silicon Prediction and Experiment Validation
por: Zhang, Dong, et al.
Publicado: (2023) -
A Pectic Polysaccharide from Sijunzi Decoction Promotes the Antioxidant Defenses of SW480 Cells
por: Huang, Chao, et al.
Publicado: (2017) -
Network Pharmacology Analysis on the Mechanism of Huangqi Sijunzi Decoction in Treating Cancer-Related Fatigue
por: Cui, Yixin, et al.
Publicado: (2021)